Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
90 participants
INTERVENTIONAL
2017-07-07
2018-10-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Subtenons Anesthesia for Postoperative Pain in Pediatric Strabismus Surgery
NCT01812044
Methadone for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery
NCT03778372
Pain Medications in Children Undergoing Strabismus Surgery
NCT02789969
Comparison Between Peribulbar And Sub-tenon Blocks on Oculocardiac Reflex (OCR) During Pediatric Strabismus Surgery
NCT06293586
Effect of Intravenous Nalbuphine on Emergence Agitation
NCT03470077
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
fentanyl
A bolus dose of fentanyl 2 μg/kg was administered intravenously at anesthetic induction
fentanyl group
fentanyl 2 μg/kg
remifentanil
Remifentanil was continuously infused at a rate of 0.2 μg/kg/min from anesthetic induction to the end of surgery
remifentanil group
remifentanil 0.2 μg/kg/min
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fentanyl group
fentanyl 2 μg/kg
remifentanil group
remifentanil 0.2 μg/kg/min
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* physical status was American Society of Anesthesiologists (ASA) class 1 or 2
Exclusion Criteria
* upper respiratory tract infection within 2 weeks,
* developmental delay,
* neurological or psychological disease,
* history of allergy to the drugs in our protocol were excluded in this study.
2 Years
8 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yeungnam University College of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eun Kyung Choi
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eun kyung Choi
Daegu, Korea (the Republic Of), South Korea
Yeungnam University Hospital
Daegu, Nam-gu, Daegu, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
YUMC 2017-04-071
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.